Investors

Key press releases

Key upcoming events

Key corporate presentation

Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).

Cellectis ADS (Nasdaq)

Ticker: CLLS

$9.3300

+0.1100 (1.1931%)

Prev. close
9.2200
Volume
184,119
High
9.5700
Capitalization
424.285M
Last Update: 9 hours ago

Cellectis (Euronext Growth Paris)

Ticker: ALCLS

€8.2850

+0.2650 (3.3042%)

Prev. close
8.0200
Volume
112,229
High
8.3150
Capitalization
376.763M
Last Update: about 14 hours ago

Covering research analysts

Barclays - Gena Wang

Citi - Yigal Nochomovitz

Goldman Sachs - Salveen Richter& Elisabeth Webster

Guggenheim - Michael Schmidt & Kelsey Goodwin

Jefferies - Kelly Shi

Jones Trading - Soumit Roy

Kempen - Ingrid Gafanhão

Ladenburg – Wangzhi Li

Oddo BHF - Martial Descoutures

Oppenheimer – Hartaj Singh

Portzamparc – Christophe Dombu

RW Baird - Jack Allen

Wells Fargo – Nick Abbott

William Blair – Raju Prasad

Cellectis contact information

Eric Dutang
+1 (646) 630 1748

Citibank ADR contact information

Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030

Société Générale Securities Services - Ordinary Shares contact information

Call center in English and French

Monday to Friday from 8:30am to 6pm CEST

+33 (0)2 51 85 67 89